Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-13

FDA Approved: CABERGOLINE — Supplemental Application (SOLA Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for cabergoline submitted by SOLA Pharmaceuticals, LLC, indicating approval of a supplemental/ generic version of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)